Latest News about Delix Therapeutics
Recent news which mentions Delix Therapeutics
Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects
September 09, 2024
Tickers
NEWS
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Psychedelics Companies Share Corporate Updates: Numinus, Delix, Tryp And Small Pharma
September 14, 2022
From Benzinga
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
January 18, 2022
From Benzinga
Delix Therapeutics Raises $30M In Convertible Note Financing, Will Enhance Drug Development Program
January 11, 2022
From Benzinga
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
December 08, 2021
From Benzinga
Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction
October 04, 2021
From Benzinga
'Psychedelics Without Hallucinations': Concept Get Closer To Human Trials With $70M Funding
September 27, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.